Ledger.Open graph →
SEC Form D · filed May 20, 2024

Kano Therapeutics Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Ann Dewitt · Cambridge, MADirectorFloris Engelhardt · Cambridge, MAExec · DirectorJohn Vroom · Cambridge, MADirectorAnn Dewitt · Cambridge, MADirectorFloris Engelhardt · Cambridge, MAExec · DirectorJohn Vroom · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗